# Adverse Reactions Section of Labeling for Human Prescription Drug and Biological Products — Content and Format - FDA Guidance Document

Source: https://www.keypedia.com/guidances/guidance-document/adverse-reactions-section-of-labeling-for-human-prescription-drug-and-biological-products-content-and-format/b6150333-b5b8-4dc4-96ca-a0540463e9a1

> FDA guidance document: Adverse Reactions Section of Labeling for Human Prescription Drug and Biological Products — Content and Format. Issue date: January 24, 2006. Get complete insights and analysis.

---

## Details

- Title: Adverse Reactions Section of Labeling for Human Prescription Drug and Biological Products — Content and Format
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2006-01-24
- Last Changed: 2020-04-21
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2005-D-0153">FDA-2005-D-0153</a>

## Related Documents

- [Reports on the Status of Postmarketing Study Commitments — Implementation of Section 130 of the Food and Drug Administration Modernization Act of 1997](https://www.keypedia.com/guidances/guidance-document/reports-on-the-status-of-postmarketing-study-commitments-implementation-of-section-130-of-the-food-and-drug-administration-modernization-act-of-1997/ec0f0699-da15-4639-8504-483baf9b5ea9)
- [Nonclinical Safety Evaluation of Pediatric Drug Products](https://www.keypedia.com/guidances/guidance-document/nonclinical-safety-evaluation-of-pediatric-drug-products/a5729b5c-7a6e-40c1-861d-e8acf3cd178a)
- [Clinical Studies Section of Labeling for Human Prescription Drug and Biological Products — Content and Format:  Guidance for Industry](https://www.keypedia.com/guidances/guidance-document/clinical-studies-section-of-labeling-for-human-prescription-drug-and-biological-products-content-and-format-guidance-for-industry/8675c759-b657-4818-9bed-199de1148828)